Dergiler / Fiziksel Tıp ve Rehabilitasyon Bilimleri Dergisi / 2017 / Cilt: 20 - Sayı: 1

Quality of Life in Patients with Multiple Sclerosis: Relationship with Clinical Variables

Multipl Sklerozlu Hastaların Hayat Kalitesi: İlişkili Klinik Değişkenler

Sayfa
16–23
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

In this study, we emphasize the need for registration and evaluation of clinical variables in order to improve QoL in patients suffering from MS.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: The aim of this study was to evaluate the the quality of life by a specific Quality of life (QoL) instrument and to determine the related clinical variables with QoL status in patients with definite Multiple Sclerosis (MS).
📊
Temel Bulgular & Veri:Material and Methods: Thirty-two MS patients with a mean age of 39±8.7 years were included in this study.
💡
Sonuç & Katkı:In this study, we emphasize the need for registration and evaluation of clinical variables in order to improve QoL in patients suffering from MS.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Objective: The aim of this study was to evaluate the the quality of life by a specific Quality of life (QoL) instrument and to determine the related clinical variables with QoL status in patients with definite Multiple Sclerosis (MS). Material and Methods: Thirty-two MS patients with a mean age of 39±8.7 years were included in this study. Demographic and clinical charcteristics of the patients were recorded. QoL was assessed by Multiple Sclerosis International Quality of Life (MusiQoL) scale. Disability, ambulation, coping with stress, depression, anxiety, fatigue and pain were determined respectively by EDSS (Expanded Disability Status Scale), Functional Ambulation Classification (FAC), Coping with the Stress Scale (CWSS), Beck Depression scale (BDS), Beck anxiety scale (BAS), while pain and fatique was determined by Visual Analogue Scale (VAS) pain and fatigue instruments. Results: There were 25 female and 7 male patients with mean disease duration of 8.7±6.7 years and mean score of MusiQoL of 56.5±12.35. Negative correlations were found between MusiQoL with disease duration (r= -0.565 p=0.001), BDS (r=-0.459; p=0.008), BAS (r=-0.568; p=0.038), EDSS (r=-0.708; p= 0.021) and VAS fatigue (r=-0.451; p=0.039). Positive correlations were found between MusiQoL with FAC score (r=0.424; p=0.01) and CWSS (r=0.531; p=0.002). There were no statistically significant correlation between MusiQoL and VAS pain (p>0.05). Conclusion: In this study, it was demonstrated that QoL is significantly associated with depression, anxiety, fatigue, ambulation level and the ability to cope with stress. MS symptoms and clinical variables have a negative impact on patients’ QoL. In this study, we emphasize the need for registration and evaluation of clinical variables in order to improve QoL in patients suffering from MS.

Abstract

Amaç: Bu çalışmanın amacı Multipl Skleroz (MS) tanısı olan hastalarda hastalığa spesifik bir hayat kalitesi değerlendirme ölçeği ile yaşam kalitesini değerlendirmek ve yaşam kalitesi ile klinik değişkenler arasındaki ilişkiyi incelemektir. Gereç ve Yöntemler: Yaş ortalaması 39±8,7 yıl olan 32 MS’li hasta çalışmaya dahil edildi. Demografik ve klinik özellikleri kaydedildi. Yaşam kalitesi Multıple Skleroz Yaşam Kalite İndeksi (MSYKİ) ile değerlendirildi. Disabilite, ambulasyon, stresle başa çıkma, depresyon, anksiyete, yorgunluk ve ağrı, sırasıyla Genişletilmiş Özürlülük Durum Ölçeği (GÖDÖ), Fonksiyonel Ambulasyon Skalası (FAS), Stresle Başa Çıkma Ölçeği (SBÇÖ), Beck Depresyon Skalası (BDS), Beck Anksiyete Skalası (BAS) ile değerlendirilirken, ağrı ve yorgunluk Görsel Analog Skala (GAS) ile değerlendiridi. Bulgular: 25 kadın, 7 erkek hastanın hastalık süresi ortalama 8.7±6.7 yıl ve ortalama MSYKİ skoru 56.5±12.35 idi. MSYKİ skoru ile hastalık süresi (r= - 0,565 p=0,001), BDS (r= -0,459 p=0,008), BAS ( r=-0,568 p=0,038), GÖDÖ (r=-0,708 p= 0,021) ve VAS yorgunluk (r=-0,451 p=0.039) arasında negatif yönde anlamlı korelasyon tespit edildi. MSYKİ ile FAS skoru (r=0,424 p=0,01) ve SBÇÖ (r=0,531 p=0,002) skorları arasında da pozitif yönlü anlamlı korelasyon tespit edildi. MSYKİ skoru ile VAS ağrı skoru arasında korelasyon saptanmadı (p>0,05). Sonuç: Bu çalışmada yaşam kalitesinin, depresyon, anksiyete, yorgunluk, ambulasyon seviyesi, stres ile başa çıkma becerisi ilişkili olduğu gösterilmiştir. MS semptomları ve klinik değişkenlerinin hastaların yaşam kalitesi üzerinde negatif etkileri vardır. Biz bu çalışmada MS li hastalarda yaşam kalitesinin arttırılabilmesi için klinik değişkenlerin kayıt edilmesi ve değerlendirilmesinin gerekliliğini vurgulamayı amaçladık.

🔖

Bu Makaleye Atıf Yap

TUNCAY, F., KAYGISIZ, F., BORMAN, P., KURT, E. E., ERGÜN, U. (2017). Quality of Life in Patients with Multiple Sclerosis: Relationship with Clinical Variables. Fiziksel Tıp ve Rehabilitasyon Bilimleri Dergisi, Cilt: 20 - Sayı: 1, 16–23. https://ajindex.com/articles/166009

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (7)

  1. Rubin SM. Management of multiple sclerosis: an overview. Dis Mon 2013;59(7):253-60. Murray TJ. Diagnosis and treatment of multiple sclerosis. BMJ 2006;332(7540):525-7. Vitamin D: hope on the horizon for MS prevention? Lancet Neurol 2010;9(6):555. Ziemssen T. Multiple sclerosis beyond EDSS: depression and fatigue. J Neurol Sci 2009;277 Suppl 1:S37-41. Hadgkiss EJ, Jelinek GA, Weiland TJ, Rumbold G, Mackinlay CA, Gutbrod S, et al. Health-related quality of life outcomes at 1 and 5 years after a residential retreat promoting lifestyle modification for people with multiple sclerosis. Neurol Sci 2013;34(2):187-95.
  2. Rudick RA, Miller DM. Health-related quality of life inmultiple sclerosis: current evidence,measurement and effects of disease severity and treatment. CNS Drugs 2008;22(10):827-39.
  3. Mitchell AJ, Benito-León J, González JM, Rivera-Navarro J. Quality of life and its assessment in multiple sclerosis: integrating physical and psychological components of wellbeing. Lancet Neurol 2005;4(9):556-66. Solari A. Role of health-related quality of life measures in the routine care of people with multiple sclerosis. Health Qual Life Outcomes 2005;3:16. Fernández O, Baumstarck-Barrau K, Simeoni MC, Auquier P. Patient characteristics and determinants of quality of life in an international population with multiple sclerosis: assessment using the MusiQoL and SF-36 questionnaires. Mult Scler 2011;17(10):1238-49.
  4. Baumstarck K, Boyer L, Boucekine M, Michel P, Pelletier J, Auquier P. Measuring the quality of life in patients with multiple sclerosis in clinical practice: a necessary challenge. Mult Scler Int 2013;2013:524894. Simeoni M, Auquier P, Fernandez O, Flachenecker P, Stecchi S, Constantinescu C, et al; MusiQol study group. Validation of the Multiple Sclerosis International Quality of Life questionnaire. Mult Scler 2008;14(2):219-30.
  5. Patrick DL, Deyo RA. Generic and diseasespecific measures in assessing health status and quality of life. Med Care 1989;27(3 Suppl):S217-32. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33(11): 1444-52.
  6. Gold SM, Heesen C, Schulz H, Guder U, Mönch A, Gbadamosi J, et al. Disease specific quality of life instruments in multiple sclerosis: validation of the Hamburg Quality of Life Questionnaire in Multiple Sclerosis (HAQUAMS). Mult Scler 2001;7(2):119-30.
  7. Idiman E, Uzunel F, Ozakbas S, Yozbatiran N, Oguz M, Callioglu B, et al. Cross-culturel adaptation and validati